Navigation Links
Malpractice Worry Discouraging Medical Students From Taking Up Obstetrics And Gynecology

A survey by the University of South Florida College of Medicine says that the rising number of malpractice claims in Florida is discouraging medical students// from opting for obstetrics and gynecology as their specialization. The situation means that many people do not have proper access to obstetric care. Aaron Deutsch, MD, lead author of the study and chief resident in the USF Department of Obstetrics and Gynecology released the findings of the survey at the annual meeting of he Florida Obstetric and Gynecological Society (FOGS).

The paper received the 2006 first-place resident research award from FOGS.

"Florida is already a state without enough obstetrician/gynecologists to meet the needs of patients. In some parts of the state, women must wait several months to see an obstetrician, and there are no perinatologists or maternal-fetal medicine specialists to take care of high-risk pregnancies," Dr. Deutsch said. "Our findings suggest this shortage may get even worse."

The USF researchers sent surveys to all fourth-year medical students in Florida in fall 2005. The senior year is when medical students find out where they will conduct their residencies – the period of specialized training for licensed medical graduates in their chosen medical field.

Florida mirrors a national trend of fewer medical students applying for ob/gyn residencies. The USF researchers hypothesized that student concerns about the rising cost of malpractice premiums and medical liability in Florida may contribute to the marked decline of students specializing in ob/gyn.

Half of the Florida students surveyed – 42 percent men and 58 percent women – responded. The respondents were divided into three groups – students who selected ob/gyn as a career (had applied to ob/gyn residencies); those who considered ob/gyn as a career but ultimately decided against it; and those who never considered ob/gyn. Of the students selecting a career in ob/
'"/>




Page: 1 2

Related medicine news :

1. Dr Death Faces Malpractice Case In Australia
2. Breast Cancer Survivors Worry About Infertility
3. Breast Cancer Survivors Worry About Infertility
4. Indian Government: No Reason For Worry About Bird Flu
5. Worry on the lowering of the already low birth-rate in Japan.
6. After Cancer Treatment Worry Continues – Researchers Find
7. Feeling Tired? Don’t Worry - You May Be Less Likely To Get Hur
8. Women Wary of Coronary Diseases Get Two More Risk Factors to Worry About
9. Shortage of Veterinarians Worry Public Health Experts in US
10. Indian Nationals with Foreign Medical Degrees can now practice in India
11. Meditation Works Medically
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Centegra Expands H1N1 Vaccines to General Public 2Health News:Centegra Expands H1N1 Vaccines to General Public 3Health News:Centegra Expands H1N1 Vaccines to General Public 4Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 2Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 3Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 4Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 5Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 6Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 7Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 8Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 9Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 10Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 11Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 12Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 13Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 14Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 15Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 16Health News:PeopleStreme Human Capital Releases 'New Trends in Performance Management - 2010' Whitepaper 2Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 2Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 3Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 4Health News:Approval of Michigan Smoke-Free Legislation is Historic Win for Health 2Health News:Approval of Michigan Smoke-Free Legislation is Historic Win for Health 3
Breaking Medicine Technology:Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3New Evidence Supports HPV Vaccine 50832 1New Evidence Supports HPV Vaccine 50832 2Pelosi Remarks on Economic Recovery Act at Mission Neighborhood Health Center in San Francisco 50830 1Pelosi Remarks on Economic Recovery Act at Mission Neighborhood Health Center in San Francisco 50830 2Carbohydrate acts as tumor suppressor 50828 1Carbohydrate acts as tumor suppressor 50828 2